Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer

Ampersand Biosciences was cited in the article titled, “Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer” for the Luminex analysis of samples tested performed with Rodent Map 4.0 Mouse panel at Ampersand Biosciences in Saranac Lake, NY.

Species: Mouse
Focus: Matrix metalloproteinase 9 (MMP9), Pancreatic Ductal Adenocarcinoma (PDAC), aMMP9